about
Aortic stenosis in the Dogue de BordeauxPrevalence of hypertrophic cardiomyopathy in a cohort of British Shorthair cats in Denmark.Hypertrophic cardiomyopathy in young Maine Coon cats caused by the p.A31P cMyBP-C mutation--the clinical significance of having the mutation.Acute neurological signs as the predominant clinical manifestation in four dogs with Angiostrongylus vasorum infections in Denmark.The Shepherds' Tale: A Genome-Wide Study across 9 Dog Breeds Implicates Two Loci in the Regulation of Fructosamine Serum Concentration in Belgian ShepherdsTissue-specific and substrate-specific mitochondrial bioenergetics in feline cardiac and skeletal muscles.Cardiac Dysfunction in a Porcine Model of Pediatric Malnutrition.Cardiac troponin I and T as prognostic markers in cats with hypertrophic cardiomyopathy.Ultrastructural myocardial changes in seven cats with spontaneous hypertrophic cardiomyopathy.The prevalence of the electrocardiographic J wave in the Petit Basset Griffon Vendéen compared to 10 different dog breeds.Genotype-phenotype correlation between the cardiac myosin binding protein C mutation A31P and hypertrophic cardiomyopathy in a cohort of Maine Coon cats: a longitudinal study.Efficacy and safety of imidacloprid/moxidectin spot-on solution and fenbendazole in the treatment of dogs naturally infected with Angiostrongylus vasorum (Baillet, 1866).A coprological investigation of gastrointestinal and cardiopulmonary parasites in hunting dogs in Denmark.Quantitative computed tomography evaluation of pulmonary disease.Symmetric Dimethylarginine in Cats with Hypertrophic Cardiomyopathy and Diabetes Mellitus.Comparison of four echocardiographic methods to determine left atrial size in dogs.The effects of detomidine, romifidine or acepromazine on echocardiographic measurements and cardiac function in normal horses.Suppurative Inflammation and Local Tissue Destruction Reduce the Penetration of Cefuroxime to Infected Bone Implant Cavities.Left atrial volume and function in dogs with naturally occurring myxomatous mitral valve disease.Impaired cardiac mitochondrial oxidative phosphorylation and enhanced mitochondrial oxidative stress in feline hypertrophic cardiomyopathy.Screening for aortic stenosis in the Boxer: Auscultatory, ECG, blood pressure and Doppler echocardiographic findings.Serum fructosamine concentrations in 59 dogs naturally Infected with Angiostrongylus vasorum.SOURCES AND MAGNITUDE OF VARIATION OF ECHOCARDIOGRAPHIC MEASUREMENTS IN NORMAL STANDARDBRED HORSESHeart rate variability in young, clinically healthy Dachshunds: influence of sex, mitral valve prolapse status, sampling period and time of dayHaematological and biochemical changes in dogs naturally infected with Angiostrongylus vasorum before and after treatmentINVESTIGATION INTO CARDIOVASCULAR ASSESSMENT OF CAPTIVE ADULT SCARLET IBIS ()Left atrial volume and phasic function in clinically healthy dogs of 12 different breedsCardiac troponin I in three cat breeds with hypertrophic cardiomyopathyAnalytical validation of platelet microparticle quantification in cats
P50
Q28289892-853EF99B-94ED-4792-9B8B-B746B24D8038Q34198386-3ECD5B53-7F79-4825-95E3-F6E88F98697DQ34600695-99B95F75-5BA3-4D8B-8D59-8ABA7F40C0BBQ35121878-E6C4F969-3F14-423C-BFF7-C38DC17C48F0Q35602801-D9109212-5994-41CE-BB03-8D593CC77ABEQ35807832-DF7CFA3B-F75D-4300-A150-011FD9907030Q35810369-B57E9D0E-2D4D-429F-917C-556B51B850B3Q36975314-DFC35C63-9DA3-43A6-A366-85918F8858DFQ38919758-C5960B73-6057-4877-84FC-B5DEAD06E4B1Q40069501-025979F0-8C26-4A6C-8EC2-8236F9C3B0C8Q40097989-6A516A41-37C4-47F1-A67B-889CD53611F9Q43549678-BAA82CD1-75A1-4A63-A85A-5FC4B9BA7D1BQ44795648-22481570-9456-4804-A0FE-65BEC8B80D8DQ45893071-CFDC3C46-D1BD-447B-B644-AF24911AA732Q46243153-589A2093-FD92-4488-98DC-4FF1A5A6E61CQ47316009-A02CEED5-AB4D-46E8-8839-E45168EE4D69Q48628289-975BE22F-3076-4DCB-94B8-3C31FB8769ACQ49709923-52AAE3E3-496B-47AF-94D4-C9EE13D51914Q50551612-E70EBDA4-FA88-48D0-A3AC-F838A1CEF2C3Q51650069-A3AF0941-2E32-4010-8C2F-41F00FB6ED43Q51929943-7EEF2159-90F8-4B2B-93A9-03C58C93921BQ53778695-0AEF4D86-E659-4EF4-93BB-2E3DD79142BEQ58818049-E2AD9ABA-03CC-42E5-8690-DBB222F6C13DQ61902680-55799D43-6152-48C4-892D-8D4BB78A27DFQ62381939-28DC6707-A2F3-467F-8F5E-0B357C9F6F6DQ64104209-5B651FA1-C146-44CC-99E4-7AA548199910Q87064941-60788FDB-6053-4E02-8AF8-B574BCAC8C86Q89179693-957B383D-CF94-4F83-976B-2C0F09838F6BQ91356035-CFEEAA1B-A081-4C19-9567-1605726DD35A
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
J Koch
@ast
J Koch
@en
J Koch
@es
J Koch
@nl
type
label
J Koch
@ast
J Koch
@en
J Koch
@es
J Koch
@nl
prefLabel
J Koch
@ast
J Koch
@en
J Koch
@es
J Koch
@nl
P106
P31
P496
0000-0001-8616-7888